Trevi Therapeutics, Inc.
USD18.63
+0.48 (+2.64%)
CEO
Jennifer L. Good
IPO Date
2019-05-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$18.15
Prev. Close
$18.15
Day Low
$17.79
Day High
$18.86
52W Low
$5.41
52W High
$18.86
Market Cap
$2.65B
Volume
2.80M
| 35,000 |
| $13.45 |
| 4 Jun 2026 | Meeker David P | director | A-Award | Acquired | 35,000 | $13.45 |
| 4 Jun 2026 | VANLENT ANNE | director | A-Award | Acquired | 35,000 | $13.45 |
| 4 Jun 2026 | Heffernan Michael Thomas | director | A-Award | Acquired | 35,000 | $13.45 |
| 20 Feb 2026 | Cassella James V | Chief Development Officer | A-Award | Acquired | 215,000 | $10.56 |
| 20 Feb 2026 | Galletta Christopher | See Remarks | A-Award | Acquired | 35,000 | $10.56 |
| 20 Feb 2026 | SCIASCIA THOMAS | Chief Scientific Officer | A-Award | Acquired | 85,000 | $10.56 |
| 20 Feb 2026 | GOOD JENNIFER L | director, officer: President & CEO | A-Award | Acquired | 675,000 | $10.56 |
| 20 Feb 2026 | Simon Farrell | Chief Commercial Officer | A-Award | Acquired | 160,000 | $10.56 |